drugset / Trial / NCT03742232

Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.

NCT03742232

Phase 4 Completed 399 enrolled Istituto Clinico Humanitas
RandomizedParallel-groupSingle-blindDiagnostic

Summary

This study is a multicentre randomized parallel group phase IV study comparing the bowel cleansing efficacy, safety and tolerability of PLENVU® (a 1 litre PEG Bowel Cleansing Solution) versus SELG-ESSE® (a 4 litre PEG Bowel Cleansing Solution) using a 2-Day Split Dosing Regimen.

Timeline

Start
2018-10-31
Primary completion
2020-03-31
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator PEG 4000 Unknown Oral
Subject polyethylene glycol Other / unclassified Oral